Cloning, expression, and characterization of mouse tissue factor pathway inhibitor (TFPI)

J Y Chang1, D M Monroe, J A Oliver

  • 1Center for Thrombosis and Hemostasis, University of North Carolina at Chapel Hill, 27599-7035, USA. jychang@med.unc.edu

Insights

Researchers cloned and expressed mouse tissue factor pathway inhibitor (TFPI), a key regulator of blood coagulation. This mouse TFPI inhibits multiple human clotting factors, providing valuable tools for coagulation research in mouse models.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hematology

Background:

  • Tissue factor pathway inhibitor (TFPI) is a critical regulator of blood coagulation initiation.
  • TFPI primarily inhibits factor Xa and the factor VIIa/tissue factor complex.
  • High molecular and functional similarity exists across species for TFPI.

Purpose of the Study:

  • To clone the full-length cDNA for mouse TFPI.
  • To express and functionally characterize recombinant mouse TFPI.
  • To provide resources for mouse model coagulation studies.

Main Methods:

  • PCR-based screening of a mouse macrophage cDNA library.
  • DNA and protein sequence analysis.
  • Recombinant protein expression in human kidney 293 cells and purification.
  • Functional assays using human clotting factors.

Main Results:

  • Full-length mouse TFPI cDNA was successfully cloned.
  • Mouse TFPI shares significant sequence homology with other species, particularly rat TFPI.
  • Recombinant mouse TFPI demonstrated inhibitory activity against human factors Xa, VIIa, IXa, and XIa.

Conclusions:

  • The cloned and expressed mouse TFPI is homologous to other species' TFPIs.
  • Mouse TFPI exhibits a broad inhibition spectrum against human coagulation factors.
  • This study provides essential tools and data for investigating coagulation in mouse models.